Submitted by Anonymous (not verified) on 13 August 2026 - 12:24
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 5, Status: Authorised